SCHEMBL7554032

SCHEMBL7554032

CCCCCCCCCCCCCCCCC(O)C(N)P(=O)(O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LAP3 P28838 2/20 0.63
S1PR2 O95136 5/20 0.58
S1PR1 P21453 5/20 0.58
S1PR3 Q99500 5/20 0.58
S1PR4 O95977 4/20 0.58
FDPS P14324 4/20 0.57
SPHK1 Q9NYA1 2/20 0.57
CYP2D6 P10635 2/20 0.53
GMNN O75496 1/20 0.53
LMNA P02545 1/20 0.53
POLB P06746 1/20 0.53
THPO P40225 1/20 0.53
MTOR P42345 1/20 0.53
BLM P54132 1/20 0.53
KDM4E B2RXH2 1/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
CETP P11597 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9240010 0.81 LAP3 (0.59) LAP3S1PR2S1PR1S1PR3S1PR4
Phosphoric Acid SCHEMBL16245452 0.81 CYP2D6 (0.63) LAP3S1PR2S1PR1S1PR3S1PR4
SCHEMBL2850790 0.81 LAP3 (0.63) LAP3S1PR2S1PR1S1PR3S1PR4
SCHEMBL8155290 0.78 LAP3 (0.62) LAP3S1PR2S1PR1S1PR3S1PR4
Dihydrospingosine SCHEMBL7594434 0.78 CYP2D6 (0.82) LAP3S1PR2S1PR1S1PR3S1PR4
Dihydrospingosine SCHEMBL30473323 0.78 CYP2D6 (0.82) LAP3S1PR2S1PR1S1PR3S1PR4
SCHEMBL5691588 0.78 LAP3 (1.00) LAP3S1PR2S1PR1S1PR3S1PR4
SCHEMBL1060233 0.78 LAP3 (1.00) LAP3S1PR2S1PR1S1PR3S1PR4
SCHEMBL1059770 0.78 LAP3 (1.00) LAP3S1PR2S1PR1S1PR3S1PR4
SCHEMBL9307335 0.78 LAP3 (1.00) LAP3S1PR2S1PR1S1PR3S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020173489-A1 COMPOSITIONS CONTAINING A MIXTURE OF PHOSPHOROUS COMPOUNDS AND ALKYLGLYCEROLS MAX-PLANCK-GESSELSCHAFT ZUR FORDERUNG DER WISSENSCHAFTER E.V. (DE) 2002-11-21 US disclosed
US-5916884-A CYTOTOXIC THERAPEUTIC COMPOUND; ANTITUMOR AGENT MAX-PLANCK-GESELLSCHAFT ZUR FOEDERUNG DER WISSENSCHAFTEN (DE) 1999-06-29 US disclosed
EP-0248062-B1 MEDICAMENTS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1992-05-06 EP disclosed
EP-0225608-A2 Medicine Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1987-06-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173489-A1 COMPOSITIONS CONTAINING A MIXTURE OF PHOSPHOROUS COMPOUNDS AND ALKYLGLYCEROLS PHOSPHO1, PLCG2, PPIP5K2 LAP3 3146/4885S1PR2 90/4885S1PR1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.